Literature DB >> 21864703

PGI2 as a regulator of CD4+ subset differentiation and function.

Madison G Boswell1, Weisong Zhou, Dawn C Newcomb, R Stokes Peebles.   

Abstract

Prostaglandin (PG)I(2) has important regulatory functions on the innate and adaptive immune systems. Recent experimental evidence reveals that PGI(2) modulates the development and function of CD4+ T cells subsets, including Th1, Th2, and Th17 cell responses. In vitro and in vivo studies support that PGI(2) generally has an inhibitory effect on Th1 and Th2 activation, differentiation, and cytokine production. In contrast, PGI(2) seems to enhance Th17-favoring polarization conditions, resulting in Th17 cytokine production. Therefore, PGI(2) may either promote or inhibit individual CD4+ cell subsets and impact adaptive immune responses.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864703      PMCID: PMC3215832          DOI: 10.1016/j.prostaglandins.2011.08.003

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  32 in total

Review 1.  The control of T cell activation vs. tolerance.

Authors:  Abul K Abbas
Journal:  Autoimmun Rev       Date:  2003-05       Impact factor: 9.754

Review 2.  Human prostacyclin receptor.

Authors:  Emer M Smyth; Garret A FitzGerald
Journal:  Vitam Horm       Date:  2002       Impact factor: 3.421

3.  Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice.

Authors:  Koichi Nagao; Hiroyuki Tanaka; Masato Komai; Taisei Masuda; Shuh Narumiya; Hiroichi Nagai
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04-03       Impact factor: 6.914

4.  Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice.

Authors:  Michelle A Carey; Dori R Germolec; J Alyce Bradbury; Rebecca A Gooch; Michael P Moorman; Gordon P Flake; Robert Langenbach; Darryl C Zeldin
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

5.  A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen.

Authors:  Zeina Jaffar; Kong-Sang Wan; Kevan Roberts
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

6.  Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice.

Authors:  R Stokes Peebles; Koichi Hashimoto; Jason D Morrow; Ryszard Dworski; Robert D Collins; Yuko Hashimoto; John W Christman; Kyung-Ho Kang; Kasia Jarzecka; Jamye Furlong; Daphne B Mitchell; Megha Talati; Barney S Graham; James R Sheller
Journal:  Am J Respir Crit Care Med       Date:  2002-04-15       Impact factor: 21.405

Review 7.  Immune-mediated disease pathogenesis in respiratory syncytial virus infection.

Authors:  B S Graham; T R Johnson; R S Peebles
Journal:  Immunopharmacology       Date:  2000-07-25

8.  Augmentation of allergic inflammation in prostanoid IP receptor deficient mice.

Authors:  Yoshimasa Takahashi; Shota Tokuoka; Taisei Masuda; Yousuke Hirano; Masafumi Nagao; Hiroyuki Tanaka; Naoki Inagaki; Shuh Narumiya; Hiroichi Nagai
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 9.  Prostaglandin synthases: recent developments and a novel hypothesis.

Authors:  Rachel J A Helliwell; Linda F Adams; Murray D Mitchell
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-02       Impact factor: 4.006

10.  Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness.

Authors:  Koichi Hashimoto; Barney S Graham; Mark W Geraci; Garret A FitzGerald; Karine Egan; Weisong Zhou; Kasia Goleniewska; Jamye F O'Neal; Jason D Morrow; Russell K Durbin; Peter F Wright; Robert D Collins; Tatsuo Suzutani; R Stokes Peebles
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more
  9 in total

Review 1.  The role of prostaglandins in allergic lung inflammation and asthma.

Authors:  Dru Claar; Tina V Hartert; Ray Stokes Peebles
Journal:  Expert Rev Respir Med       Date:  2014-12-26       Impact factor: 3.772

Review 2.  Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions.

Authors:  Oyebola O Oyesola; Elia D Tait Wojno
Journal:  Eur J Immunol       Date:  2021-09-07       Impact factor: 6.688

Review 3.  Regulation of T helper cell subsets by cyclooxygenases and their metabolites.

Authors:  Hong Li; Matthew L Edin; Artiom Gruzdev; Jennifer Cheng; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-11-28       Impact factor: 3.072

Review 4.  Prostaglandins in asthma and allergic diseases.

Authors:  R Stokes Peebles
Journal:  Pharmacol Ther       Date:  2018-08-03       Impact factor: 12.310

Review 5.  Polyunsaturated Fatty Acid-derived lipid mediators and T cell function.

Authors:  Anna Nicolaou; Claudio Mauro; Paula Urquhart; Federica Marelli-Berg
Journal:  Front Immunol       Date:  2014-02-25       Impact factor: 7.561

6.  Hypoxia-hindered methylation of PTGIS in endometrial stromal cells accelerates endometriosis progression by inducing CD16- NK-cell differentiation.

Authors:  Haiyan Peng; Lichun Weng; Shating Lei; Shuhui Hou; Shaoliang Yang; Mingqing Li; Dong Zhao
Journal:  Exp Mol Med       Date:  2022-07-04       Impact factor: 12.153

7.  Proinflammatory and immunoregulatory roles of eicosanoids in T cells.

Authors:  Anna Mari Lone; Kjetil Taskén
Journal:  Front Immunol       Date:  2013-06-04       Impact factor: 7.561

8.  Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination.

Authors:  C Takahashi; R Muramatsu; H Fujimura; H Mochizuki; T Yamashita
Journal:  Cell Death Dis       Date:  2013-09-12       Impact factor: 8.469

9.  Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1.

Authors:  Nathalie Andrieu-Abadie; Céline Colacios; Caroline Imbert; Anne Montfort; Marine Fraisse; Elie Marcheteau; Julia Gilhodes; Elodie Martin; Florie Bertrand; Marlène Marcellin; Odile Burlet-Schiltz; Anne Gonzalez de Peredo; Virginie Garcia; Stéphane Carpentier; Sophie Tartare-Deckert; Pierre Brousset; Philippe Rochaix; Florent Puisset; Thomas Filleron; Nicolas Meyer; Laurence Lamant; Thierry Levade; Bruno Ségui
Journal:  Nat Commun       Date:  2020-01-23       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.